SAI LIFE SCIENCES LTD. share price has zoomed 6% and is presently trading at Rs 829.1.
Meanwhile, the BSE HEALTHCARE index is at 44,135.1 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are Aurobindo Pharma (up 1.5%) and SYNGENE INTERNATIONAL (up 0.7%).
ALEMBIC PHARMA (down 2.7%) and NARAYANA HRUDAYALAYA (down 2.0%) are among the top losers today.
Over the last one year, SAI LIFE SCIENCES LTD. has moved up from Rs 0.0 to Rs 829.1, registering a gain of Rs 829.1 .
On the other hand, the BSE HEALTHCARE index has moved up from 37,251.2 to 44,135.1, registering a gain of 18.5% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were LAURUS LABS (up 73.7%), NARAYANA HRUDAYALAYA (up 68.8%) and ASTER DM HEALTHCARE (up 68.5%).
Last Day: Access Our 4 Foundational Stock Recommendation Services at 75% OFF
The BSE Sensex is at 83,669.1 .
The top losers among the BSE Sensex today are Indusind Bank (down 3.3%) and Bajaj Finserv (down 1.3%). The most traded stocks in the BSE Sensex are Eternal Ltd and M&M.
In the meantime, NSE Nifty is at 25,507.7 (down 0.1%). Indusind Bank and Shriram Transport are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 79,476.2 to 83,669.1, registering a gain of 4,192.9 points (up 5.3%).
SAI LIFE SCIENCES LTD. net profit fell {profitpercent} YoY to Rs 883 million for the quarter ended March 2025, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 5,795 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2024, SAI LIFE SCIENCES LTD. reported 729.0% increase in net profit to Rs 828 million compared to net profit of Rs 100 million during FY23. Revenue of the company grew 20.4% to Rs 14,652 million during FY24.
Image source: StarLineArts/www.istockphoto.com
Equitymaster requests your view! Post a comment on "SAI LIFE SCIENCES LTD. Gains 6%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!